The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory reponse induced by oxysterol and TNF-α

Redox Report

Volumn 9, Issue 6, 2004, Pages 354-359

  Shimozawa, Makoto ^a   Naito, Yuji ^a   Manabe, Hiroki ^a   Uchiyama, Kazuhiko ^a   Katada, Kazuhiro ^a   Kuroda, Masaaki ^a   Nakabe, Nami ^a   Yoshida, Norimasa ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adhesion molecule; Alacepril; Angiotensin converting enzyme inhibitor; Aortic endothelial cell; Monocyte adhesion

Indexed keywords

7 OXOCHOLESTEROL; ALACEPRIL; CAPTOPRIL; CELL ADHESION MOLECULE; DEACETYLALACEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; OXYSTEROL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL ASSAY; CELL INTERACTION; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; INHIBITION KINETICS; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CELL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; ENDOTHELIUM, VASCULAR; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KETOCHOLESTEROLS; MONOCYTES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 13244268621     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100004225006876     Document Type: Article

References (16)

1. Itoh K, Yoshida S, Fukuda M. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits - critical analysis with new ultrasound technique. Jpn Circ J 1994; 58: 844-854.
2. Miyazaki M, Takai S. Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res 1999; 22: 49-54.
3. Russell JC, Graham SE, Amy RM, Dolphin PJ. Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril. J Cardiovasc Pharmacol 1998; 31: 971-977.
4. Suzuki M, Teramoto S, Katayama H, Ohga E, Matsuse T, Ouchi Y. Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages. J Asthma 1999; 36: 665-670.
5. Noda Y, Anzai K, Mori A, Kohno M, Shinmei M, Packer L. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem Mol Biol Int 1997; 42: 35-44.
6. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963-20966.
7. Dong ZM, Wagner DD. Leukocyte-endothelium adhesion molecules in atherosclerosis. J Lab Clin Med 1998; 132: 369-375.
8. Yoshida N, Manabe H, Terasawa Y et al. Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. Biofactors 2000; 13: 279-288.
9. Matsumoto K, Miyazaki H, Fujii T, Yoshida K, Amejima H, Hashimoto M. Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneimittelforschung 1986; 36: 40-46.
10. Mak IT, Freedman AM, Dickens BF, Weglicki WB. Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 1990; 40: 2169-2175.
11. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol 1992; 19: 330-340.
12. Cominacini L, Pasini A, Garbin U et al. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am J Hypertens 2002; 15: 891-895.
13. Mira ML, Silva MM, Manso CF. The scavenging of oxygen free radicals by angiotensin-converting enzyme inhibitors: the importance of the sulfhydryl group in the chemical structure of the compounds. Ann NY Acad Sci 1994; 723: 439-441.
14. Lizard G, Gueldry S, Sordet O et al. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 1998; 12: 1651-1663.
15. True AL, Rahman A, Malik AB. Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol 2000; 279: L302-L311.
16. Higgins JP. Can angiotensin-converting enzyme inhibitors reverse atherosclerosis? South Med J 2003; 96: 569-579.